Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Virology Journal
Published in: Virology Journal 1/2022

Open Access 01-12-2022 | Prednisolone | Research

Determining host factors contributing to the reactivation of JC virus in kidney transplant recipients

Authors: Sajedeh Keykhosravi, Masoud Khosravi, Mohammad Shenagari, Elham Hasan-alizadeh, Mehrdad Mosadegh, Narjes Noori Goodarzi, Ali Monfared, Babak Ashrafkhani, Tolou Hasandokht

Published in: Virology Journal | Issue 1/2022

Login to get access

Abstract

Background and aims

The John Cunningham virus (JCV) is the established etiological agent of the polyomavirus-associated nephropathy among renal transplant recipients. In the present study, we aimed to determine the probable predictive factors leading to JCV replication in renal transplant patients.

Material and methods

Urine and plasma samples were collected from a total of 120 consecutive renal‐transplanted patients without preliminary screening from Jan 2018 to Mar 2019. After DNA extraction, the simultaneous detection and quantification of JCV and BK polyomavirus (BKV) were conducted using a Real-time quantitative PCR method. Moreover, statistical analyses were performed using the statistical software packages, SPSS version 21.

Results

The prevalence of JCV viruria and viremia among renal transplant recipients were 26 (21.67%) and 20 (16.67%), respectively. A significant association was observed between the JCV and two risk factors, diabetes mellitus (P = 0.002) and renal stones (P = 0.015). The prevalence of JCV viremia among recipients who were grafted near time to sampling was significantly higher (P = 0.02). There was a statistically significant coexistence between BK and JC viruses among our patients (P = 0.029). The frequency of JCV viruria in males was reported almost three times more than in females (P = 0.005). The JCV shedding in urine was significantly associated with the tropical steroids like prednisolone acetate, which have been the standard regimen (P = 0.039). Multivariable analysis revealed duration of post-transplantation (OR, 0.89; P = 0.038), diabetes mellitus (OR, 1.85; P = 0.034), and renal stone (OR 1.10; P = 0.04) as independent risk factors associated with JCV viremia post-renal transplantation.

Conclusion

It seems that the discovery of potential risk factors, including immunological and non-immunological elements, may offer a possible preventive or therapeutic approach in the JCV disease episodes. The results of this study may also help clarify the probable clinical risk factors involving in progressive multifocal leukoencephalopathy development.
Literature
1.
Padgett B, Zurhein G, Walker D, Eckroade R, Dessel B. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet. 1971;297(7712):1257–60.CrossRef
2.
Gardner S, Field A, Coleman D, Hulme B. New human papovavirus (BK) isolated from urine after renal transplantation. Lancet. 1971;297(7712):1253–7.CrossRef
3.
Delbue S, Branchetti E, Boldorini R, Vago L, Zerbi P, Veggiani C, et al. Presence and expression of JCV early gene large T antigen in the brains of immunocompromised and immunocompetent individuals. J Med Virol. 2008;80(12):2147–52.PubMedPubMedCentralCrossRef
4.
Ferenczy MW, Marshall LJ, Nelson CD, Atwood WJ, Nath A, Khalili K, et al. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev. 2012;25(3):471–506.PubMedPubMedCentralCrossRef
5.
Nqebelele NU, Dickens C, Dix-Peek T, Duarte R, Naicker S. JC virus and APOL1 risk alleles in black South Africans with hypertension-attributed CKD. Renal Int Rep. 2019;4(7):939–45.
6.
Swinnen B, Saegeman V, Beuselinck K, Wouters A, Cypers G, Meyfroidt G, et al. Predictive value of JC virus PCR in cerebrospinal fluid in the diagnosis of PML. Diagn Microbiol Infect Dis. 2019;95(3):114859.PubMedCrossRef
7.
8.
Crowder CD, Gyure KA, Drachenberg CB, Werner J, Morales RE, Hirsch HH, et al. Successful outcome of progressive multifocal leukoencephalopathy in a renal transplant patient. Am J Transpl. 2005;5(5):1151–8.CrossRef
9.
Boukoum H, Nahdi I, Sahtout W, Skiri H, Segondy M, Aouni M. BK and JC virus infections in healthy patients compared to renal transplant recipients in Tunisia. Microb Pathog. 2016;97:204–8.PubMedCrossRef
10.
Lamarche C, Orio J, Collette S, Senécal L, Hébert M-J, Renoult É, et al. BK polyomavirus and the transplanted renal: immunopathology and therapeutic approaches. Transplantation. 2016;100(11):2276.PubMedPubMedCentralCrossRef
11.
Delbue S, Ferraresso M, Ghio L, Carloni C, Carluccio S, Belingheri M, et al. A review on JC virus infection in renal transplant recipients. Clin Dev Immunol. 2013;2013:926391.
12.
Padgett BL, Walker DL. Virologic and serologic studies of progressive multifocal leukoencephalopathy. Prog Clin Biol Res. 1983;105:107–17.PubMed
13.
Brooks BR, Walker DL. Progressive multifocal leukoencephalopathy. Neurol Clin. 1984;2(2):299–313.PubMedCrossRef
14.
Shenagari M, Monfared A, Eghtedari H, Pourkazemi A, Hasandokht T, Khosravi M, et al. BK virus replication in renal transplant recipients: analysis of potential risk factors may contribute in reactivation. J Clin Virol. 2017;96:7–11.PubMedCrossRef
15.
Hu J, Li S, Yang M, Xu L, Zhang X, Zhao H, et al. Incidence, risk factors and the effect of polyomavirus infection in hematopoietic stem cell transplant recipients. J Int Med Res. 2017;45(2):762–70.PubMedPubMedCentralCrossRef
16.
Höcker B, Schneble L, Murer L, Carraro A, Pape L, Kranz B, et al. Epidemiology of and risk factors for BK polyomavirus replication and nephropathy in pediatric renal transplant recipients: an international CERTAIN Registry study. Transplantation. 2019;103(6):1224–33.PubMedCrossRef
17.
Melliez H, Mary-Krause M, Bocket L, Guiguet M, Abgrall S, De Truchis P, et al. Risk of progressive multifocal leukoencephalopathy in the combination antiretroviral therapy era in the French hospital database on human immunodeficiency virus (ANRS-C4). Clin Infect Dis. 2018;67(2):275–82.PubMedCrossRef
18.
Tan CS, Bord E, Broge TA Jr, Glotzbecker B, Mills H, Gheuens S, et al. Increased program cell death-1 (PD-1) expression on T lymphocytes of patients with progressive multifocal leukoencephalopathy (PML). J Acquir Immune Defic Syndr. 2012;60(3):244.PubMedPubMedCentralCrossRef
19.
20.
Neil EC, DeAngelis LM. Progressive multifocal leukoencephalopathy and hematologic malignancies: a single cancer center retrospective review. Blood Adv. 2017;1(23):2041–5.PubMedPubMedCentralCrossRef
21.
Puri V, Chaudhry N, Gulati P, Patel N, Tatke M, Sinha S. Progressive multifocal leukoencephalopathy in a patient with idiopathic CD4+ T lymphocytopenia. Neurol India. 2010;58(1):118.PubMedCrossRef
22.
Rudnicka D, Oszmiana A, Finch DK, Strickland I, Schofield DJ, Lowe DC, et al. Rituximab causes a polarization of B cells that augments its therapeutic function in NK-cell–mediated antibody-dependent cellular cytotoxicity. Blood J Am Soc Hematol. 2013;121(23):4694–702.
23.
Marshall LJ, Dunham L, Major EO. Transcription factor Spi-B binds unique sequences present in the tandem repeat promoter/enhancer of JC virus and supports viral activity. J Gen Virol. 2010;91(Pt 12):3042.PubMedPubMedCentralCrossRef
24.
Nukuzuma S, Nakamichi K, Kameoka M, Sugiura S, Nukuzuma C, Miyoshi I, et al. Efficient propagation of progressive multifocal leukoencephalopathy-type JC virus in COS-7-derived cell lines stably expressing Tat protein of human immunodeficiency virus type 1. Microbiol Immunol. 2010;54(12):758–62.PubMedCrossRef
25.
Khalili A, Craigie M, Donadoni M, Sariyer IK. Host-immune interactions in JC virus reactivation and development of progressive multifocal leukoencephalopathy (PML). J Neuroimmune Pharmacol. 2019;14(4):649–60.PubMedPubMedCentralCrossRef
26.
Sariyer IK, Khalili K. Regulation of human neurotropic JC virus replication by alternative splicing factor SF2/ASF in glial cells. PLoS ONE. 2011;6(1):e14630.PubMedPubMedCentralCrossRef
27.
Craigie M, Regan P, Otalora Y-L, Sariyer IK. Molecular interplay between T-Antigen and splicing factor, arginine/serine-rich 1 (SRSF1) controls JC virus gene expression in glial cells. Virol J. 2015;12(1):1–7.CrossRef
28.
Ravichandran V, Sabath BF, Jensen PN, Houff SA, Major EO. Interactions between c-Jun, nuclear factor 1, and JC virus promoter sequences: implications for viral tropism. J Virol. 2006;80(21):10506–13.PubMedPubMedCentralCrossRef
29.
Ranganathan PN, Khalili K. The transcriptional enhancer element, x B, regulates promoter activity of the human neurotropic virus, JCV, in cells derived from the CNS. Nucleic Acids Res. 1993;21(8):1959–64.PubMedPubMedCentralCrossRef
30.
Stettner MR, Nance JA, Wright CA, Kinoshita Y, Kim W-K, Morgello S, et al. SMAD proteins of oligodendroglial cells regulate transcription of JC virus early and late genes coordinately with the Tat protein of human immunodeficiency virus type 1. J Gen Virol. 2009;90(Pt 8):2005.PubMedPubMedCentralCrossRef
31.
Randhawa P, Baksh F, Aoki N, Tschirhart D, Finkelstein S. JC virus infection in allograft renals: analysis by polymerase chain reaction and immunohistochemistry. Transplantation. 2001;71(9):1300–3.PubMedCrossRef
32.
Kazory A, Ducloux D, Chalopin J-M, Angonin R, Fontanière B, Moret H. The first case of JC virus allograft nephropathy. Transplantation. 2003;76(11):1653–5.PubMedCrossRef
33.
Wen MC, Wang CL, Wang M, Cheng CH, Wu MJ, Chen CH, et al. Association of JC virus with tubulointerstitial nephritis in a renal allograft recipient. J Med Virol. 2004;72(4):675–8.PubMedCrossRef
34.
Kantarci G, Eren Z, Demirağ A, Dogan I, Cakalagaoglu F, Yilmaz G. JC virus-associated nephropathy in a renal transplant recipient and comparative analysis of previous cases. Transpl Infect Dis. 2011;13(1):89–92.PubMedCrossRef
35.
36.
Cheng XS, Bohl DL, Storch GA, Ryschkewitsch C, Gaudreault-Keener M, Major EO, et al. Inhibitory interactions between BK and JC virus among renal transplant recipients. J Am Soc Nephrol. 2011;22(5):825–31.PubMedPubMedCentralCrossRef
37.
Hussain I, Tasneem F, Gilani US, Arshad MI, ul Haque MF, Abbas Z, et al. Human BK and JC polyomaviruses: molecular insights and prevalence in Asia. Virus Res. 2020;278:197860.PubMedCrossRef
38.
Yoon S-H, Cho J-H, Jung H-Y, Choi J-Y, Park S-H, Kim Y-L, et al. Clinical impact of BK virus surveillance on outcomes in renal transplant recipients. In: Transplantation proceedings: Elsevier; 2015. p. 660–5.
39.
Bozorgi SM, Tahaei SME, Mohebbi SR, Sahba N, Damavand B, Romani S, et al. Molecular prevalence of JC virus in Tehran, Iran. Gastroenterol Hepatol Bed Bench. 2012;5(2):84.PubMedPubMedCentral
40.
Sadeghi F, Salehi-Vaziri M, Ghodsi SM, Alizadeh A, Bokharaei-Salim F, Saroukalaei ST, et al. Prevalence of JC polyomavirus large T antigen sequences among Iranian patients with central nervous system tumors. Adv Virol. 2015;160(1):61–8.
41.
Pourjabari K, Makvandi M, Kaydani G, Shahbazian H, Samarbaf-Zadeh AR. Prevalence, reactivation and genotyping of John Cunningham virus among end-stage renal disease and renal transplant patients. Futur Virol. 2016;11(7):489–96.CrossRef
42.
Husseiny MI, Anastasi B, Singer J, Lacey SF. A comparative study of Merkel cell, BK and JC polyomavirus infections in renal transplant recipients and healthy subjects. J Clin Virol. 2010;49(2):137–40.PubMedPubMedCentralCrossRef
43.
Taheri S, Kafilzadeh F, Shafa M, Yaran M, Mortazavi M, Seirafian S, et al. Comparison of polyomavirus (BK virus and JC viruses) viruria in renal transplant recipients with and without renal dysfunction. J Res Med Sci. 2011;16(7):916.PubMedPubMedCentral
44.
Saundh BK, Tibble S, Baker R, Sasnauskas K, Harris M, Hale A. Different patterns of BK and JC polyomavirus reactivation following renal transplantation. J Clin Pathol. 2010;63(8):714–8.PubMedCrossRef
45.
Helanterä I, Ortiz F, Auvinen E, Räisänen-Sokolowski A, Lappalainen M, Lautenschlager I, et al. Polyomavirus BK and JC infections in well matched Finnish renal transplant recipients. Transpl Int. 2009;22(7):688–93.PubMedCrossRef
46.
Pires E, Bernardino-Vallinoto C, Alves D, Migone S, Machado L, Ishak M, et al. Prevalence of infection by JC and BK polyomaviruses in renal transplant recipients and patients with chronic renal disease. Transpl Infect Dis. 2011;13(6):633–7.PubMedCrossRef
47.
Mengelle C, Kamar N, Mansuy JM, Sandres-Sauné K, Legrand-Abravanel F, Miédougé M, et al. JC virus DNA in the peripheral blood of renal transplant patients: A 1-year prospective follow-up in France. J Med Virol. 2011;83(1):132–6.PubMedCrossRef
48.
Randhawa P, Uhrmacher J, Pasculle W, Vats A, Shapiro R, Eghtsead B, et al. A comparative study of BK and JC virus infections in organ transplant recipients. J Med Virol. 2005;77(2):238–43.PubMedCrossRef
49.
Drachenberg CB, Hirsch HH, Papadimitriou JC, Gosert R, Wali RK, Munivenkatappa R, et al. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation. Transplantation. 2007;84(3):323–30.PubMedCrossRef
50.
Yin W-Y, Lu M-C, Lee M-C, Liu S-C, Lin T-Y, Lai N-S. A correlation between polyomavirus JC virus quantification and genotypes in renal transplantation. Am J Surg. 2010;200(1):53–8.PubMedCrossRef
51.
Zalona ACJ, Varella RB, Takiya CM, Goncalves RT, Zalis MG, Santoro-Lopes G. A qualitative seminested PCR assay as an alternative to urine cytology for BK polyomavirus screening after renal transplantation. Intervirology. 2013;56(4):249–52.PubMedCrossRef
Metadata
Title
Determining host factors contributing to the reactivation of JC virus in kidney transplant recipients
Authors
Sajedeh Keykhosravi
Masoud Khosravi
Mohammad Shenagari
Elham Hasan-alizadeh
Mehrdad Mosadegh
Narjes Noori Goodarzi
Ali Monfared
Babak Ashrafkhani
Tolou Hasandokht
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
Prednisolone
Published in
Virology Journal / Issue 1/2022
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-022-01843-w

Other articles of this Issue 1/2022

Virology Journal 1/2022 Go to the issue

Brief Report

Epidemiological and genetic characteristics of porcine circovirus 3 in 15 provinces and municipalities of China between 2016 and 2020

Review

Effects of electromagnetic waves on pathogenic viruses and relevant mechanisms: a review

Research

Application of a VP4/VP2-inferred transmission clusters in estimating the impact of interventions on rhinovirus transmission

Research

Human infection with a reassortant swine-origin influenza A(H1N2)v virus in Taiwan, 2021

Research

Molecular characteristics of norovirus in sporadic and outbreak cases of acute gastroenteritis and in sewage in Sichuan, China

Research

Functional analysis of a viral promoter from a strawberry vein banding virus isolate from China
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits